Interpreting Liver Enzymes

A mildly elevated ALT is one of the most common abnormalities on routine labs. Knowing how to interpret the pattern — not just the number — determines whether you reassure, retest, or refer.

  • Distinguish hepatocellular from cholestatic injury patterns using AST, ALT, ALP, and GGT elevations
  • Calculate the R-ratio and apply it to categorize a liver injury pattern on a given set of labs
  • Generate a prioritized differential diagnosis for any liver enzyme pattern encountered on rounds
13 min · 5 sectionsInterpretation
Reading mode
On this page
  1. 01The Basic Panel
  2. 02Pattern Recognition
  3. 03Magnitude Matters
  4. 04When to Repeat vs. Refer
  5. 05Clinical Application
Progress0/5

The standard liver function panel includes markers of hepatocyte injury, cholestasis, synthetic function, and bilirubin metabolism. Understanding what each measures clarifies what an abnormality means:

Transaminases (Hepatocellular Injury Markers)

  • ALT (Alanine Aminotransferase): More liver-specific than AST. The primary marker of hepatocyte injury. Elevated in most forms of liver disease.
  • AST (Aspartate Aminotransferase): Also found in cardiac muscle, skeletal muscle, kidney, and brain. Less specific for the liver. Important in the AST:ALT ratio.
Your lab's "normal" ALT is probably too high
Most laboratories report an ALT upper limit of normal around 40–55 IU/L, because those ranges were derived from populations that included people with undiagnosed liver disease. The ACG defines the true healthy normal ALT as 29–33 IU/L for males and 19–25 IU/L for females, and recommends that levels above this be assessed rather than dismissed.

Practical consequence: a "normal-per-lab" ALT of 38 in a woman is above the healthy normal range and, with metabolic risk factors, still deserves evaluation. Do not let the lab's reference interval end the conversation.

Cholestatic Markers

  • ALP (Alkaline Phosphatase): Elevated in biliary obstruction, infiltrative disease, and bone disease. Also elevated in pregnancy (placental isoform). Check GGT to confirm hepatic origin.
  • GGT (Gamma-Glutamyl Transferase): Highly sensitive for hepatic origin of ALP elevation. Also elevated with alcohol use, fatty liver, and many medications. Poor specificity in isolation.

Bilirubin

  • Total bilirubin: Sum of conjugated (direct) and unconjugated (indirect) fractions.
  • Direct (conjugated) bilirubin elevation → hepatic or post-hepatic cause
  • Indirect (unconjugated) bilirubin elevation → pre-hepatic (hemolysis) or Gilbert syndrome

Synthetic Function Markers

  • Albumin: Synthesized exclusively by the liver. Low albumin reflects reduced hepatic synthetic capacity (half-life ~20 days — chronic marker).
  • PT/INR: Reflects clotting factors made by the liver. Prolonged INR in liver disease indicates synthetic dysfunction (acute marker, half-life hours to days).
References
  1. Kwo PY, Cohen SM, Lim JK. ACG clinical guideline: evaluation of abnormal liver chemistries. Am J Gastroenterol. 2017;112(1):18-35. PubMed 27995906 (primary guideline for this topic)
  2. Giannini EG, Testa R, Savarino V. Liver enzyme alteration: a guide for clinicians. CMAJ. 2005;172(3):367-379. PubMed 15684121
  3. Chalasani N, Bonkovsky HL, Fontana R, et al. Features and outcomes of 899 patients with drug-induced liver injury: the DILIN prospective study. Gastroenterology. 2015;148(7):1340-1352. PubMed 25754159
  4. National Institute of Diabetes and Digestive and Kidney Diseases. LiverTox: clinical and research information on drug-induced liver injury. www.ncbi.nlm.nih.gov/books/NBK547852/